According to the report by Allied Market Research, titled, “Erythropoietin Drugs Market by Product Type (Epoetin-Alfa, Epoetin-Beta, and Darbepoetin-Alfa, Others) and Application (Hematology, Kidney Disorder, Cancer, Others): Global Opportunity Analysis and Industry Forecast, 2021–2028″. The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.

Rise in prevalence of cancer, HIV, anemia, and kidney diseases, surge in level of awareness about the benefits of EPO therapeutics, and commercialization for erythropoietin biosimilars drive the growth of the global erythropoietin drugs market. However, longer duration of treatment, unaffordability of therapeutics, and adverse amount of side effects hinder the market growth. On the contrary, the commercialization of darbepoetin alfa biosimilar and achieving economies of scale across developed regions are expected to open lucrative opportunities for the market players in the future.

For Right Perspective and Competitive Insights, Get Sample Report at: 

The global erythropoietin drugs market size was valued at $9,243.12 million in 2020, and is projected to reach $14,414.59 million by 2028, registering a CAGR of 5.7% from 2021 to 2028.

Based on product type, the epoetin-alfa segment held the lion’s share in 2020, accounting for more than two-fifths of the market. However, the darbepoetin-alfa segment is estimated to register the highest CAGR of 7.0% during the forecast period.

Comprehensive competitive analysis and profiles of major market players, such as

  • Johnson & Johnson
  • Amgen Inc
  • Roche, Hospira Inc.
  • Biocon
  • LG Life Sciences Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Intas Pharmaceuticals
  • Ranbaxy Laboratories Ltd.
  • Celltrion, Inc.


On the basis of product, the epoetin-alfa held largest share in the global erythropoietin drugs market in 2020.

On the basis of application, the kidney disorders held the largest erythropoietin drugs market share in 2020, and is expected to remain dominant throughout the forecast period. 

By region, North America is expected to experience growth at the highest rate, during the forecast period. 

Get detailed COVID-19 impact analysis@ Request For Customization:-


Q1. What is the market value of erythropoietin drugs market report in forecast period?

Q2. What would be forecast period in the market report?

Q3. What is the market value of erythropoietin drugs market in 2021?

Q4. Which is base year calculated in the erythropoietin drugs market Report?

Q5. Does the erythropoietin drugs market Company is profiled in the report?

Q6. Which are the top companies hold the market share in erythropoietin drugs market?

Q7. Does the erythropoietin drugs market report provide Value Chain Analysis?

Q8. What are the key trends in the erythropoietin drugs market report?

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial:

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report titles for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.